ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities.

April 19, 2002

OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation”

December 13, 1974

In Brief: OMB tells NCI Mislead Congress, Refuses Higher Budget; Ford Says He Support Program

March 28, 1975

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997

Peters Replaced As Director Of Karmanos Cancer Center.

December 1, 2000